Robert James Wills, Director at CymaBay Therapeutics, Inc. (CBAY), bought 50,000 shares at $2.43 ($122K) on 2016-09-06, disclosed to the SEC on 2016-09-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.43 | 25,000 | $61K | 50.0% |
| 2 | $2.43 | 25,000 | $61K | 50.0% |
| Total | $2.43 avg | 50,000 | $122K | 100% |
| Filing → |
| ONCT | BUY | 2024-04-10 | $28K | — | Filing → |
| ONCT | BUY | 2024-04-01 | $117K | — | Filing → |
| ONCT | SELL | 2024-02-27 | $9K | — | Filing → |